Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's disease. - Roby DA; Ruiz F; Kermath BA; Voorhees JR; Niehoff M; Zhang J; Morley JE; Musiek ES; Farr SA; Burris TP (PloS one, 2019)